Integrated Filing — IndAS

General information about company
Scrip Code	512070
NSE Symbol	UPL
MSEI Symbol	NOTLISTED
ISIN	INE628A01036
Name of company	UPL LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	12-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Refer note in results for segment
Start date and time of board meeting	12-May-2025   10:45:00
End date and time of board meeting	12-May-2025   13:15:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-05-12
Indicate Company website link for updated RPT policy of the Company	https://www.upl-ltd.com/investors/corporate-governance/policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	20110000000	53300000000
	Other income	100000000	1470000000
	Total income	20210000000	54770000000
2	Expenses
(a)	Cost of materials consumed	4510000000	18830000000
(b)	Purchases of stock-in-trade	16620000000	23290000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-3390000000	1620000000
(d)	Employee benefit expense	600000000	1890000000
(e)	Finance costs	510000000	2310000000
(f)	Depreciation, depletion and amortisation expense	340000000	1350000000
(f)	Other Expenses
1	Impairment (write back)/ loss on financial assets	-110000000	-120000000
2	Exchange rate difference on receivables and payables (net)	300000000	30000000
3	Other expenses	2280000000	6240000000
	Total other expenses	2470000000	6150000000
	Total expenses	21660000000	55440000000
3	Total profit before exceptional items and tax	-1450000000	-670000000
4	Exceptional items	18570000000	21120000000
5	Total profit before tax	17120000000	20450000000
6	Tax expense
7	Current tax	420000000	-5260000000
8	Deferred tax	-690000000	-720000000
9	Total tax expenses	-270000000	-5980000000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	17390000000	26430000000
12	Profit (loss) from discontinued operations before tax	0	3390000000
13	Tax expense of discontinued operations	0	430000000
14	Net profit (loss) from discontinued operation after tax	0	2960000000
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	17390000000	29390000000
17	Other comprehensive income net of taxes	-20000000	-60000000
18	Total Comprehensive Income for the period	17370000000	29330000000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	1590000000	1590000000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		118620000000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	22.16	34.29
	Diluted earnings (loss) per share from continuing operations	21.65	33.49
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	3.84
	Diluted earnings (loss) per share from discontinued operations	0	3.75
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	22.16	38.13
	Diluted earnings (loss) per share from continuing and discontinued operations	21.65	37.24
24	Debt equity ratio	0.0005	0.0005
25	Debt service coverage ratio	-0.0209	0.0222
26	Interest service coverage ratio	-0.0209	0.0222
27	Disclosure of notes on financial results		For detailed notes refer signed results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	6600000000
	Capital work-in-progress	1040000000
	Investment property
	Goodwill	0
	Other intangible assets	890000000
	Intangible assets under development	240000000
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	54780000000
	Trade receivables, non-current
	Loans, non-current	34370000000
	Other non-current financial assets	7760000000
	Total non-current financial assets	96910000000
	Deferred tax assets (net)	670000000
	Other non-current assets	60000000
	Total non-current assets	106410000000
2	Current assets
	Inventories	4400000000
	Current financial asset
	Current investments	500000000
	Trade receivables, current	36940000000
	Cash and cash equivalents	1040000000
	Bank balance other than cash and cash equivalents	330000000
	Loans, current	50000000
	Other current financial assets	760000000
	Total current financial assets	39620000000
	Current tax assets (net)	0
	Other current assets	27730000000
	Total current assets	71750000000
3	Non-current assets classified as held for sale	1250000000
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	179410000000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	1590000000
	Other equity	118620000000
	Total equity attributable to owners of parent	120210000000
	Non controlling interest
	Total equity	120210000000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	200000000
	Total non-current financial liabilities	200000000
	Provisions, non-current	350000000
	Deferred tax liabilities (net)
	Deferred government grants, Non-current
	Other non-current liabilities	14360000000
	Total non-current liabilities	14910000000
	Current liabilities
	Current financial liabilities
	Borrowings, current	5700000000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	90000000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	28010000000
	Total Trade payable	28100000000
	Other current financial liabilities	780000000
	Total current financial liabilities	34580000000
	Other current liabilities	9640000000
	Provisions, current	70000000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	44290000000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	59200000000
	Total equity and liabilites	179410000000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	30000000	80000000
3	Amount of items that will be reclassified to profit and loss
1	Income tax relating to items that will not be reclassified to profit or loss	10000000	20000000
	Total Amount of items that will be reclassified to profit and loss	10000000	20000000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-20000000	-60000000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			20450000000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			3510000000
	Adjustments for decrease (increase) in inventories			-300000000
	Adjustments for decrease (increase) in trade receivables, current			-28200000000
	Adjustments for decrease (increase) in trade receivables, non-current			13730000000
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			0
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			4670000000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			120000000
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			840000000
	Adjustments for interest income			180000000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-3030000000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-18860000000
	Other adjustments to reconcile profit (loss)			3390000000
	Other adjustments for non-cash items			30000000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			-180000000
	Total adjustments for reconcile profit (loss)			-26140000000
	Net cash flows from (used in) operations			-5690000000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			3540000000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			-9230000000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			38710000000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			2550000000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			330000000
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			27670000000
	Purchase of other long-term assets			-21640000000
	Cash advances and loans made to other parties			400000000
	Cash receipts from repayment of advances and loans made to other parties			200000000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			840000000
	Interest received			70000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	8430000000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			16330000000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			7240000000
	Repayments of borrowings			19810000000
	Payments of lease liabilities			170000000
	Dividends paid			770000000
	Interest paid			2440000000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			380000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-420000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-420000000
	Cash and cash equivalents cash flow statement at beginning of period			1460000000
	Cash and cash equivalents cash flow statement at end of period			1040000000

Signatory Details
Name of signatory	Sandeep Deshmukh
Designation of person	Company Secretary and Compliance Officer
Place	Mumbai
Date	12-May-2025